Skip to main content

Nasdaq News

NBCUniversal Unveils Originals Available at Launch of Peacock

6 years 5 months ago
On Thursday, NBCUniversal, the studio arm of Comcast (NASDAQ: CMCSA), announced its slate of original programming that will be available to users of streaming service Peacock when it launches on July 15. Viewers will be treated to nine original series or movies, with content ran

Novavax (NVAX): Next Stop, $150?

6 years 5 months ago

For the biotech sector, volatility is nothing new. Stocks can surge or crash depending on regulatory approval or rejection. The same is true following the release of encouraging or disappointing clinical data.

That being said, vaccine developer Novavax’s (NVAX) recent spectacular rally is on another level. The stock surged by another 63% on May 12, cumulatively accruing 921% worth of gains in 2020.

The latest share price appreciation came after it was announced that the coalition for Epidemic Preparedness Innovations (CEPI) will commit up to $388 million to further the development of Novavax’s vaccine candidate against COVID-19 (SARS-CoV-2), NVX-CoV2373. The investment is the CEPI’s biggest to date, and follows up its initial $4 million grant to Novavax, which now seems miniscule in comparison. 

In tandem with setting the process of clinical trials in motion (with Phase 1/2 trial data expected by July), part of the funding will go towards ramping up production at various locations around the globe, with a target of matching the largest pharma vaccine developers’ production capacity.

Based on Novavax’s vaccine track record, Ladenburg analyst Michael Higgins is confident in the outcome, and predicts the Phase 1/2 results “will prove to be safe.” The results are a key component of Novavax’s rNPV (risk-adjusted net present value) as the data will have an impact on the “scale up activities.”

Accordingly, Higgins reiterated a Buy rating on Novavax shares, while boosting his price target from $38 to $50. Higgins wrote that the increased price target reflects his "continued confidence in the successful completion of development and global approval of NVX-CoV2373, with an increased estimate for the procurement of this vaccine in 2021, from 100M to 300M doses, at $10/dose, for a ~3% share of global vaccine consumption, with our continued assumption for a $5 CGS/dose." (To watch Higgins’ track record, click here)

Overall, Novavax gets 100% support from the Street, as all 5 analysts tracked over the last three months rate the vaccine player a Buy. With an average price target of $45.60, the analyst fraternity projects upside potential of 19%. (See Novavax stock analysis on TipRanks)

Read more:

Stock Market Wrap-Up: The Surprise Leader in Thursday's Rebound

6 years 5 months ago
The stock market rose on Thursday, finally regaining some lost ground from earlier in the week. Even though worries about the economic fallout from the coronavirus pandemic aren't going away anytime soon, investors seemed a little bit more comfortable with the possibility that t

RSI Alert: ForeScout Technologies (FSCT) Now Oversold

6 years 5 months ago
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which

FUJIF Crosses Below Key Moving Average Level

6 years 5 months ago
In trading on Thursday, shares of Fuji Photo Film Ltd (Symbol: FUJIF) crossed below their 200 day moving average of $47.38, changing hands as low as $46.41 per share. Fuji Photo Film Ltd shares are currently trading down about 2.9% on the day. The chart below shows the one y

American National Insurance (ANAT) Passes Through 5% Yield Mark

6 years 5 months ago
Looking at the universe of stocks we cover at Dividend Channel, in trading on Thursday, shares of American National Insurance Co. (Symbol: ANAT) were yielding above the 5% mark based on its quarterly dividend (annualized to $3.28), with the stock changing hands as low as $64.

WU Crosses Above 5% Yield Territory

6 years 5 months ago
Looking at the universe of stocks we cover at Dividend Channel, in trading on Thursday, shares of Western Union Co (Symbol: WU) were yielding above the 5% mark based on its quarterly dividend (annualized to $0.9), with the stock changing hands as low as $17.55 on the day. Div
Checked
15 minutes 10 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article
Subscribe to Nasdaq News feed